Skip to main content
SpringerLink
Log in

Infection Control and Prevention Considerations

  • Chapter
  • First Online:
Infectious Complications in Cancer Patients

Part of the book series: Cancer Treatment and Research ((CTAR,volume 161))

Abstract

Due to the nature of their underlying illness and treatment regimens, cancer patients are at increased risk of infection. Though the advent and widespread use of anti-infective agents has allowed for the application of ever-greater immune-suppressing therapies with successful treatment of infectious complications, prevention of infection remains the primary goal. The evolutionary changes of microorganisms, whereby resistance to anti-infective therapy is increasingly common, have facilitated a paradigm shift in the field of healthcare epidemiology. No longer is the focus on “control” of infection once established in a healthcare environment. Rather, the emphasis is on prevention of infection before it occurs. The most basic tenet of infection prevention, and the cornerstone of all well-designed infection prevention and control programs, is hand hygiene. The hands of healthcare workers provide a common potential source for transmission of infectious agents, and effective decontamination of the hands reduces the risk of transmission of infectious material to other patients. Once infection is suspected or established; however, implementation of effective control strategies is important to limit the spread of infection within a healthcare environment. This chapter outlines the basic tenets of infection prevention, principles of isolation precautions and control measures, and elements for a successful infection control and prevention program.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. CDC (1992) The nation’s prevention agency. MMWR Morb Mortal Wkly Rep 41(44):833

    Google Scholar 

  2. Hugonnet S, Pittet D (2000) Hand hygiene-beliefs or science? Clin Microbiol Infect 6(7):350–356

    PubMed  CAS  Google Scholar 

  3. Talbot TR et al (2013) Sustained improvement in hand hygiene adherence: utilizing shared accountability and financial incentives. Infect Control Hosp Epidemiol 34(11):1129–1136

    Google Scholar 

  4. Schneider J et al (2009) Hand hygiene adherence is influenced by the behavior of role models. Pediatr Crit Care Med 10(3):360–363

    PubMed  Google Scholar 

  5. Lankford MG et al (2003) Influence of role models and hospital design on hand hygiene of healthcare workers. Emerg Infect Dis 9(2):217–223

    PubMed Central  PubMed  Google Scholar 

  6. Siegel JD et al (2007) Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 35(10(2)):S65–S164

    PubMed  Google Scholar 

  7. Use of Surgical Masks and Respirators in Health Care Settings (2010) Oct 2006 (cited 26 Apr 2010). Available from www.pandemicflu.gov/professional/hospital/maskguidancehc.html

  8. Bean B, Braun C, Balfour HH Jr (1982) Acyclovir therapy for acute herpes zoster. Lancet 2(8290):118–121

    PubMed  CAS  Google Scholar 

  9. Leclair JM et al (1980) Airborne transmission of chickenpox in a hospital. N Engl J Med 302(8):450–453

    PubMed  CAS  Google Scholar 

  10. Papineni RS, Rosenthal FS (1997) The size distribution of droplets in the exhaled breath of healthy human subjects. J Aerosol Med 10(2):105–116

    PubMed  CAS  Google Scholar 

  11. Feigin RD et al (1982) Epidemic meningococcal disease in an elementary-school classroom. N Engl J Med 307(20):1255–1257

    PubMed  CAS  Google Scholar 

  12. Dick EC et al (1987) Aerosol transmission of rhinovirus colds. J Infect Dis 156(3):442–448

    PubMed  CAS  Google Scholar 

  13. Siegel JD et al (2007) Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35(10(2)):S165–S193

    PubMed  Google Scholar 

  14. Moody K, Charlson ME, Finlay J (2002) The neutropenic diet: what’s the evidence? J Pediatr Hematol Oncol 24(9):717–721

    PubMed  Google Scholar 

  15. Pizzo PA, Purvis DS, Waters C (1982) Microbiological evaluation of food items. For patients undergoing gastrointestinal decontamination and protected isolation. J Am Diet Assoc 81(3):272–279

    PubMed  CAS  Google Scholar 

  16. Schlesinger A et al (2009) Infection-control interventions for cancer patients after chemotherapy: a systematic review and meta-analysis. Lancet Infect Dis 9(2):97–107

    PubMed  Google Scholar 

  17. Dykewicz CA, Jaffe HW, Kaplan JE (2000) Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 49(RR-10):1–125, CE 1–7

    Google Scholar 

  18. Supriya M et al (2009) Controlling MRSA in head and neck cancer patients: what works? Otolaryngol Head Neck Surg 140(2):224–227

    PubMed  Google Scholar 

  19. Reitzel RA et al (2009) Efficacy of novel antimicrobial gloves impregnated with antiseptic dyes in preventing the adherence of multidrug-resistant nosocomial pathogens. Am J Infect Control 37(4):294–300 (Epub 19 Jan 2009)

    PubMed  Google Scholar 

  20. Wenzel RP, Bearman G, Edmond MB (2008) Screening for MRSA: a flawed hospital infection control intervention. Infect Control Hosp Epidemiol 29(11):1012–1018

    PubMed  Google Scholar 

  21. Wang FD et al (2008) Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Am J Infect Control 36(2):118–122

    PubMed  Google Scholar 

  22. Rogers SN et al (2008) Which patients are most at risk of methicillin resistant Staphylococcus aureus: a review of admissions to a regional maxillofacial ward between 2001 and 2005. Br J Oral Maxillofac Surg 46(6):439–444

    PubMed  Google Scholar 

  23. Hidron AI et al (2008) NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 29(11):996–1011

    PubMed  Google Scholar 

  24. Miyake M et al (2007) Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) and use of a nasal mupirocin ointment in oral cancer inpatients. J Oral Maxillofac Surg 65(11):2159–2163

    PubMed  Google Scholar 

  25. Scudeller L et al (2000) MRSA carriage: the relationship between community and healthcare setting. A study in an Italian hospital. J Hosp Infect 46(3):222–229

    PubMed  CAS  Google Scholar 

  26. Robicsek A et al (2008) Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148(6):409–418

    PubMed  Google Scholar 

  27. Harbarth S et al (2008) Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299(10):1149–1157

    PubMed  CAS  Google Scholar 

  28. Cosgrove SE et al (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36(1):53–59

    PubMed  Google Scholar 

  29. Worth LJ et al (2007) Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur J Haematol 79(3):226–233

    PubMed  Google Scholar 

  30. Huang SS et al (2007) Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis 195(3):339–346

    PubMed  CAS  Google Scholar 

  31. Matar MJ et al (2006) Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 34(8):534–536

    PubMed  Google Scholar 

  32. Knoll M et al (2005) Outbreak of vancomycin-resistant enterococci (VRE) in a hematological oncology ward and hygienic preventive measures. A long-term study. Onkologie 28(4):187–192

    PubMed  Google Scholar 

  33. Oh HS et al (2004) Outbreak of vancomycin resistant Enterococcus in a hematology/oncology unit in a Korean University Hospital, and risk factors related to patients, staff, hospital care and facilities. Scand J Infect Dis 36(11–12):790–794

    PubMed  Google Scholar 

  34. Husni R et al (2002) Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer. Infect Control Hosp Epidemiol 23(2):102–103

    PubMed  Google Scholar 

  35. Hanna H et al (2001) Management of an outbreak of vancomycin-resistant Enterococci in the medical intensive care unit of a cancer center. Infect Control Hosp Epidemiol 22(4):217–219

    PubMed  CAS  Google Scholar 

  36. McCarthy KM et al (2000) Control of an outbreak of vancomycin-resistant Enterococcus faecium in an oncology ward in South Africa: effective use of limited resources. J Hosp Infect 44(4):294–300

    PubMed  CAS  Google Scholar 

  37. Kuehnert MJ et al (1999) Association between mucositis severity and vancomycin-resistant enterococcal bloodstream infection in hospitalized cancer patients. Infect Control Hosp Epidemiol 20(10):660–663

    PubMed  CAS  Google Scholar 

  38. Roord JJ et al (1986) Infection prevention during induction of remission in children with newly diagnosed acute leukemia. Ann Ist Super Sanita 22(3):973–977

    PubMed  CAS  Google Scholar 

  39. Olivier CN et al (2008) Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE. Infect Control Hosp Epidemiol 29(5):404–409

    PubMed  Google Scholar 

  40. Fuller RE et al (1998) Vancomycin-resistant enterococci: risk related to the use of intravenous vancomycin in a university hospital. Infect Control Hosp Epidemiol 19(11):821–823

    PubMed  CAS  Google Scholar 

  41. Sakka V et al (2008) Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci. Clin Microbiol Infect 14(1):14–21

    PubMed  CAS  Google Scholar 

  42. Dan M et al (1999) Rectal colonization with vancomycin-resistant enterococci among high-risk patients in an Israeli hospital. J Hosp Infect 43(3):231–238

    PubMed  CAS  Google Scholar 

  43. Beltrami EM et al (2000) Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control 28(4):282–285

    PubMed  CAS  Google Scholar 

  44. MacIntyre CR et al (2001) Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital. Infect Control Hosp Epidemiol 22(10):624–629

    PubMed  CAS  Google Scholar 

  45. Zaas AK et al (2002) Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 35(10):1139–1146

    PubMed  Google Scholar 

  46. Martinez JA et al (2003) Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 163(16):1905–1912

    PubMed  Google Scholar 

  47. Padiglione AA et al (2003) Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob Agents Chemother 47(8):2492–2498

    PubMed Central  PubMed  CAS  Google Scholar 

  48. McEvoy SP et al (2006) Risk factors for the acquisition of vancomycin-resistant enterococci during a single-strain outbreak at a major Australian teaching hospital. J Hosp Infect 62(2):256–258

    PubMed  CAS  Google Scholar 

  49. Assadian O et al (2007) Prevalence of vancomycin-resistant enterococci colonization and its risk factors in chronic hemodialysis patients in Shiraz. Iran BMC Infect Dis 7:52

    Google Scholar 

  50. Askarian M et al (2008) Risk factors for rectal colonization with vancomycin-resistant enterococci in Shiraz. Iran Int J Infect Dis 12(2):171–175

    Google Scholar 

  51. Dubberke ER et al (2006) Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? Bone Marrow Transplant 38(12):813–819

    PubMed  CAS  Google Scholar 

  52. Han SH et al (2009) Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome. J Infect 58(3):182–190

    PubMed  Google Scholar 

  53. DiazGranados CA et al (2005) Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41(3):327–333

    PubMed  Google Scholar 

  54. DiazGranados CA, Jernigan JA (2005) Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 191(4):588–595

    PubMed  CAS  Google Scholar 

  55. Weinstock DM et al (2007) Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 13(5):615–621

    PubMed  Google Scholar 

  56. Siddiqui AH et al (2002) The effect of active surveillance for vancomycin-resistant enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. Am J Infect Control 30(1):40–43

    PubMed  Google Scholar 

  57. Livermore DM (2009) Has the era of untreatable infections arrived? J Antimicrob Chemother 64(1):i29–i36

    PubMed  CAS  Google Scholar 

  58. Hawkey PM, Jones AM (2009) The changing epidemiology of resistance. J Antimicrob Chemother 64(1):i3–i10

    PubMed  CAS  Google Scholar 

  59. Gould IM (2008) The epidemiology of antibiotic resistance. Int J Antimicrob Agents 32(1):S2–S9

    PubMed  CAS  Google Scholar 

  60. Septimus EJ, Kuper KM (2009) Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century. Clin Pharmacol Ther 86(3):336–339

    PubMed  CAS  Google Scholar 

  61. Walsh TR (2008) Clinically significant carbapenemases: an update. Curr Opin Infect Dis 21(4):367–371

    PubMed  Google Scholar 

  62. Falagas ME, Bliziotis IA (2006) Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 10(2):R48

    PubMed Central  PubMed  Google Scholar 

  63. Falagas ME et al (2009) Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol 4:1103–1109

    PubMed  Google Scholar 

  64. Falagas ME, Kopterides P, Siempos II (2006) Attributable mortality of Acinetobacter baumannii infection among critically ill patients. Clin Infect Dis 43(3):389; author reply 389–390

    Google Scholar 

  65. Furtado GH et al (2009) Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: Risk factors and mortality. J Crit Care 24(4):625 (epub 9 Jul 2009, e9–e14)

    Google Scholar 

  66. Hakki M et al (2007) Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplant 39(11):687–693

    PubMed  CAS  Google Scholar 

  67. Krcmery V Jr et al (1998) Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study. J Chemother 10(4):320–325

    PubMed  Google Scholar 

  68. Zavascki AP et al (2006) The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 58(2):387–392

    PubMed  CAS  Google Scholar 

  69. Zavascki AP et al (2006) Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study. Crit Care 10(4):R114

    PubMed Central  PubMed  Google Scholar 

  70. Daniels TL et al (2008) Mortality rates associated with multidrug-resistant Acinetobacter baumannii infection in surgical intensive care units. Infect Control Hosp Epidemiol 29(11):1080–1083

    PubMed  Google Scholar 

  71. Sunenshine RH et al (2007) Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization. Emerg Infect Dis 13(1):97–103

    PubMed Central  PubMed  Google Scholar 

  72. Morrell M, Fraser VJ, Kollef MH (2005) Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49(9):3640–3645

    PubMed Central  PubMed  CAS  Google Scholar 

  73. Lodise TP Jr et al (2007) Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother 51(10):3510–3515

    PubMed Central  PubMed  CAS  Google Scholar 

  74. Kollef MH et al (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115(2):462–474

    PubMed  CAS  Google Scholar 

  75. Reddy P et al (2007) Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis 45(7):846–852

    PubMed  CAS  Google Scholar 

  76. Santos RP, Mayo TW, Siegel JD (2008) Healthcare epidemiology: active surveillance cultures and contact precautions for control of multidrug-resistant organisms: ethical considerations. Clin Infect Dis 47(1):110–116

    PubMed  Google Scholar 

  77. Maragakis LL et al (2008) Incidence and prevalence of multidrug-resistant acinetobacter using targeted active surveillance cultures. JAMA 299(21):2513–2514

    PubMed  CAS  Google Scholar 

  78. Bartlett JG et al (1978) Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med 298(10):531–534

    PubMed  CAS  Google Scholar 

  79. Johnson S et al (1990) Nosocomial Clostridium difficile colonisation and disease. Lancet 336(8707):97–100

    PubMed  CAS  Google Scholar 

  80. Kuijper EJ et al (2001) Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain. Eur J Clin Microbiol Infect Dis 20(8):528–534

    PubMed  CAS  Google Scholar 

  81. Muto CA et al (2005) A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26(3):273–280

    PubMed  Google Scholar 

  82. Mekonen ET et al (2002) Predominance of a single restriction endonuclease analysis group with intrahospital subgroup diversity among Clostridium difficile isolates at two Chicago hospitals. Infect Control Hosp Epidemiol 23(11):648–652

    PubMed  Google Scholar 

  83. Manian FA, Meyer L, Jenne J (1996) Clostridium difficile contamination of blood pressure cuffs: a call for a closer look at gloving practices in the era of universal precautions. Infect Control Hosp Epidemiol 17(3):180–182

    PubMed  CAS  Google Scholar 

  84. Kaatz GW et al (1988) Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 127(6):1289–1294

    PubMed  CAS  Google Scholar 

  85. Brooks S et al (1998) Reduction in vancomycin-resistant Enterococcus and Clostridium difficile infections following change to tympanic thermometers. Infect Control Hosp Epidemiol 19(5):333–336

    PubMed  CAS  Google Scholar 

  86. Gaynes R et al (2004) Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 38(5):640–645

    PubMed  Google Scholar 

  87. Komatsu M et al (2003) High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection. Eur J Clin Microbiol Infect Dis 22(9):525–529

    PubMed  CAS  Google Scholar 

  88. Pulvirenti JJ et al (2002) Difference in the incidence of Clostridium difficile among patients infected with human immunodeficiency virus admitted to a public hospital and a private hospital. Infect Control Hosp Epidemiol 23(11):641–647

    PubMed  Google Scholar 

  89. Talon D et al (1995) Use of pulsed-field gel electrophoresis for investigation of an outbreak of Clostridium difficile infection among geriatric patients. Eur J Clin Microbiol Infect Dis 14(11):987–993

    PubMed  CAS  Google Scholar 

  90. McFarland LV, Surawicz CM, Stamm WE (1990) Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 162(3):678–684

    PubMed  CAS  Google Scholar 

  91. Brown E et al (1990) Risk factors for Clostridium difficile toxin-associated diarrhea. Infect Control Hosp Epidemiol 11(6):283–290

    PubMed  CAS  Google Scholar 

  92. Safdar N, Maki DG (2002) The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, Enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 136(11):834–844

    PubMed  Google Scholar 

  93. Blot E et al (2003) Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. J Hosp Infect 53(3):187–192

    PubMed  CAS  Google Scholar 

  94. Gifford AH, Kirkland KB (2006) Risk factors for Clostridium difficile-associated diarrhea on an adult hematology-oncology ward. Eur J Clin Microbiol Infect Dis 25(12):751–755

    PubMed  CAS  Google Scholar 

  95. McDonald LC et al (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353(23):2433–2441

    PubMed  CAS  Google Scholar 

  96. Warny M et al (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366(9491):1079–1084

    PubMed  CAS  Google Scholar 

  97. Kuijper EJ et al (2008) Update of Clostridium difficile infection due to PCR ribotype 027 in Europe. Euro Surveill 13(31)

    Google Scholar 

  98. Boone N et al (1998) Evaluation of an interdisciplinary re-isolation policy for patients with previous Clostridium difficile diarrhea. Am J Infect Control 26(6):584–587

    PubMed  CAS  Google Scholar 

  99. Hanna H et al (2000) Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol 21(3):226–228

    PubMed  CAS  Google Scholar 

  100. Delmee M et al (1987) Epidemiology and prevention of Clostridium difficile infections in a leukemia unit. Eur J Clin Microbiol 6(6):623–627

    PubMed  CAS  Google Scholar 

  101. Sherertz RJ et al (1987) Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 83(4):709–718

    PubMed  CAS  Google Scholar 

  102. Sehulster L, Chinn RY (2003) Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 52(RR-10):1–42

    Google Scholar 

  103. Haiduven D (2009) Nosocomial aspergillosis and building construction. Med Mycol 47(1):S210–S216

    PubMed  CAS  Google Scholar 

  104. Maschmeyer G, Haas A, Cornely OA (2007) Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs 67(11):1567–1601

    PubMed  CAS  Google Scholar 

  105. Carter CD, Barr BA (1997) Infection control issues in construction and renovation. Infect Control Hosp Epidemiol 18(8):587–596

    PubMed  CAS  Google Scholar 

  106. Gustafson TL et al (1983) Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis 148(2):230–238

    PubMed  CAS  Google Scholar 

  107. Palmore TN et al (2009) A cluster of cases of nosocomial legionnaires disease linked to a contaminated hospital decorative water fountain. Infect Control Hosp Epidemiol 30(8):764–768

    PubMed Central  PubMed  Google Scholar 

  108. Meletis J et al (1987) Legionnaires’ disease after bone marrow transplantation. Bone Marrow Transplant 2(3):307–313

    PubMed  CAS  Google Scholar 

  109. Parry MF et al (1985) Waterborne Legionella bozemanii and nosocomial pneumonia in immunosuppressed patients. Ann Intern Med 103(2):205–210

    PubMed  CAS  Google Scholar 

  110. Neill MA et al (1985) Nosocomial legionellosis, Paris, France. Evidence for transmission by potable water. Am J Med 78(4):581–588

    PubMed  CAS  Google Scholar 

  111. Arnow PM et al (1982) Nosocomial Legionnaires’ disease caused by aerosolized tap water from respiratory devices. J Infect Dis 146(4):460–467

    PubMed  CAS  Google Scholar 

  112. Garbe PL et al (1985) Nosocomial Legionnaires’ disease. Epidemiologic demonstration of cooling towers as a source. JAMA 254(4):521–524

    PubMed  CAS  Google Scholar 

  113. Levin AS (2009) Nosocomial legionellosis: prevention and management. Expert Rev Anti Infect Ther 7(1):57–68

    PubMed  Google Scholar 

  114. Fiore AE et al (2009) Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 58(RR-8):1–52

    Google Scholar 

  115. Talbot TR et al (2005) Influenza vaccination of healthcare workers and vaccine allocation for healthcare workers during vaccine shortages. Infect Control Hosp Epidemiol 26(11):882–890

    PubMed  Google Scholar 

  116. Lemaitre M et al (2009) Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. J Am Geriatr Soc 57(9):1580–1586

    PubMed  Google Scholar 

  117. Hayward AC et al (2006) Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ 333(7581):1241

    PubMed Central  PubMed  Google Scholar 

  118. Carman WF et al (2000) Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet 355(9198):93–97

    PubMed  CAS  Google Scholar 

  119. Potter J et al (1997) Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis 175(1):1–6

    PubMed  CAS  Google Scholar 

  120. Babcock HM et al (2009) Mandatory influenza vaccination: translating policy to practice, in Society for Healthcare Epidemiology of America 19th annual scientific meeting. San Diego, CA

    Google Scholar 

  121. Stone PW et al (2009) Staffing and structure of infection prevention and control programs. Am J Infect Control 37(5):351–357

    PubMed Central  PubMed  Google Scholar 

  122. Richards C et al (2001) Characteristics of hospitals and infection control professionals participating in the National Nosocomial Infections Surveillance System 1999. Am J Infect Control 29(6):400–403

    PubMed  CAS  Google Scholar 

  123. Haley RW et al (1980) The SENIC Project. Study on the efficacy of nosocomial infection control (SENIC Project). Summary of study design. Am J Epidemiol 111(5):472–485

    PubMed  CAS  Google Scholar 

  124. O’Boyle C, Jackson M, Henly SJ (2002) Staffing requirements for infection control programs in US health care facilities: Delphi project. Am J Infect Control 30(6):321–333

    PubMed  Google Scholar 

  125. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36(5):309–332

    PubMed  Google Scholar 

  126. Edwards JR et al (2008) National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control 36(9):609–626

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Vanderbilt University School of Medicine, Vanderbilt University Medical Center, A2200 MCN, 1161 21 AVE S, Nashville, TN, 37232, USA

    Titus L. Daniels

  2. Vanderbilt University School of Medicine, Vanderbilt University Medical Center, A2200 MCN, 1161 21 AVE S, Nashville, TN, 37232, USA

    Thomas R. Talbot

Authors
  1. Titus L. Daniels
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas R. Talbot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Titus L. Daniels .

Editor information

Editors and Affiliations

  1. Div. Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

    Valentina Stosor

  2. Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

    Teresa R. Zembower

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Daniels, T.L., Talbot, T.R. (2014). Infection Control and Prevention Considerations. In: Stosor, V., Zembower, T. (eds) Infectious Complications in Cancer Patients. Cancer Treatment and Research, vol 161. Springer, Cham. https://doi.org/10.1007/978-3-319-04220-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-04220-6_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-04219-0

  • Online ISBN: 978-3-319-04220-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation